ALLEGAN, Mich. — Michigan has added Padagis' over-the-counter Naloxone HCl Nasal Spray 4 mg to the state’s distribution network. The partnership will help expand access to life-saving medication and maximize the impact of federal overdose prevention funding in the state.
“Michigan distributed more than 419,000 naloxone kits last fiscal year and now that they are supplementing with our generic version this year the state can stretch its funding further and reach even more people,” said Padagis president Pamela Hoffman. “Increasing access to naloxone is a key factor for states aiming to reduce opioid overdose deaths. We’re proud to be able to provide our home state of Michigan with high-quality, life-saving medication at a significantly lower cost.”
Padagis will distribute its naloxone spray to more than 1,000 sites across Michigan through its dedicated portal, which also offers training materials on recognizing opioid overdoses and education on proper nasal spray administration.
“At Padagis, we’re committed to reducing healthcare costs and improving access to essential medications. Our partnership with the State of Michigan reflects that mission,” continued Hoffman. “Since launching our OTC naloxone in 2023, we’ve focused on lowering barriers to this critical medication, and we’re proud to make it more accessible and affordable right here in our home state. Michigan is setting a powerful example of how to maximize federal and state resources to protect public health and serve its communities.”
To learn more about Padagis and its OTC naloxone nasal spray, visit padagisnaloxone.com.